LS5 Lunch session: IFPMA and IFPW – Shaping a sound supply chain

LS5 Lunch session: IFPMA and IFPW – Shaping a sound supply chain

Invited Session
Location: Room 3 Date: April 21, 2016 Time: 12:30 pm - 2:00 pm

Background:

In December 2015, the World Health Organization (WHO) held a consultation with global health stakeholders to identify bottlenecks and barriers in the pharmaceutical supply chain resulting in limited or no supply of medicines to patients. This consultation follows the work of other health stakeholders like the European Medicines Agency and its 2012-2015 implementation plan for medicine shortages caused by manufacturing & compliance issues. This discussion is expected to continue in international fora such as the upcoming World Health Assembly in May.

 

General objective:

Present conference participants with a holistic overview of the opportunities & challenges facing the pharmaceutical supply chain today and the potential impact on global health.

 

Specific topic addressed:

  • Pharmaceutical Supply Chain
  • Globalization of Manufacturing, Quality & Supply
  • Good Distribution Practices, Good Manufacturing Practices, Good Supply Practices
  • Falsified Medicines and Product Verification Systems

 

 

ID Name of the moderator Organisation Country
LS5/0

Sukaina Virji

News Editor,

Scrip Intelligence

Presentations:

ID Title of the presentation Name of participant Organisation Country
LS5/1

Round Table Discussion - Shaping a sound supply chain

Lisa Hedman or Sue Hill

WHO

Switzerland

 

John Kalland

(Walgreens Boots Alliance), International Federation of Pharmaceutical Wholesalers (IFPW)

 

Cheryl Watson

(BMS), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

 

Christophe Hambye

(TBC), International Committee of the Red Cross (ICRC)

Switzerland

 

IFPMA_logo

ifpwlogo